Loading...
Market
Increase in Sanofi's vaccine production capacity by mid-2025?
5
Resolution / Starting Odds
Yes • 50%
No • 50%
Sanofi production data, healthcare industry reports
Story
Sanofi Invests $1.08 Billion in French Biomanufacturing, Boosts EU Health Sovereignty
May 13, 2024, 06:45 AM
Sanofi announced plans to invest over 1 billion euros ($1.08 billion) to enhance its drug and vaccine production capabilities across three of its sites in France. This investment aims to expand biomanufacturing capacities and is part of a broader initiative to promote health sovereignty within the European Union.
View original story
Similar markets
COVID-19 vaccines • 33%
Influenza vaccines • 33%
Other vaccines • 34%
Pre-clinical • 25%
Phase 1 • 25%
Phase 2 • 25%
Phase 3 • 25%
Yes • 50%
No • 50%
0 contracts • 25%
1-2 contracts • 25%
3-4 contracts • 25%
5 or more contracts • 25%
Less than 500 jobs • 25%
500-999 jobs • 25%
1000-1499 jobs • 25%
1500 or more jobs • 25%